Monday, January 6, 2014
Aegerion Pharma (AEGR) - UPDATE: Stock Gaps, Volatility Explodes... But We Knew This Would Happen on Friday... Didn't We?
AEGR is trading $68.82, down 6.4% with IV30™ exploding up 19.8%. The Symbol Summary is included below.
Provided by Livevol
Aegerion Pharmaceuticals, Inc. (Aegerio) is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat lipid disorders
This is a follow up to the article I posted on Friday (1-3-2014) which specifically noted the rising downside risk in AEGR as expressed by the options. You can read that post by clicking on the title below:
Aegerion Pharma (AEGR) - Calendar Spread Opens; Options Read: Elevated Downside Risk in Short-term
The Symbol Summary from Friday is included below, as a reference. Note the difference in the stock price and the IV30™.
Provided by Livevol
Here's a quick summary of that post, below:
---
1-3-2014
Let's start with the Skew Tab, below.
Provided by Livevol
I note two things:
1. First, obviously ever strike in Jan is priced above Feb in terms of volatility.
2. Second, that vol difference expands between the two months as we move to the out-of-the-money (OTM) puts. We'll come back to that in a second.
To read more about skew, what is and why it exists you can click the title below:
Understanding Option Skew -- What it is and Why it Exists.
Finally, let's look to the Options Tab (below).
Provided by Livevol
While Jan to Feb shows ~12 vol point difference in the at-the-money (ATM) options, check out, as one example, the Jan/Feb 60 put spread. That shows a vol difference of 94.67% to 76.13% or ~ 18 vol points. The option market reflects greater downside risk in the near-term for AEGR relative to the medium-term. That creates a nice calendar vol spread to analyze.
---
And now, back to today. The stock is down, the volatility is exploding, and how about that skew? Let's turn to the Skew Tab today:
Provided by Livevol
Check out those vol levels relative to the ones in the Skew Tab from Friday (above). To make it explicit, I have included the Options Tab, for Just January, below.
Provided by Livevol
Explicit comparisons:
Provided by Livevol
So we can see a pretty much across the board rise of 25 vol points in each strike. Who would have thought the stock would gap down before January 17th (Jan expiry)?... Oh wait...
This is trade analysis, not a recommendation.
Follow @OphirGottlieb
Tweet
Legal Stuff:
Options involve risk. Prior to buying or selling an option, an investor must receive a copy of Characteristics and Risks of Standardized Options. Investors need a broker to trade options, and must meet suitability requirements.
The information contained on this site is provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation. Consult the appropriate professional advisor for more complete and current information. I am not engaged in rendering any legal or professional services by placing these general informational materials on this website.
I specifically disclaim any liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential, or special damages arising out of or in any way connected with access to or use of the site, even if I have been advised of the possibility of such damages, including liability in connection with mistakes or omissions in, or delays in transmission of, information to or from the user, interruptions in telecommunications connections to the site or viruses.
I make no representations or warranties about the accuracy or completeness of the information contained on this website. Any links provided to other server sites are offered as a matter of convenience and in no way are meant to imply that I endorse, sponsor, promote or am affiliated with the owners of or participants in those sites, or endorse any information contained on those sites, unless expressly stated.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment